STOCK TITAN

CONMED Corporation - CNMD STOCK NEWS

Welcome to our dedicated page for CONMED Corporation news (Ticker: CNMD), a resource for investors and traders seeking the latest updates and insights on CONMED Corporation stock.

CONMED Corporation (symbol: CNMD) is a global leader in medical technology, specializing in the development and sale of innovative surgical and patient monitoring products. Headquartered in Utica, New York, CONMED employs approximately 3,500 individuals who are dedicated to improving healthcare quality through high-quality product design, production, and marketing.

The company's core business encompasses a diverse range of specialties, including orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. These products are known for their technological advancements, enabling physicians to deliver superior care and achieve enhanced clinical outcomes for their patients.

CONMED operates through two primary reporting units: Orthopedic Surgery and General Surgery. Geographically, the company is U.S.-centric, with the majority of its revenue generated domestically. The EMEA region contributes the second-largest revenue share, followed by APAC and the non-U.S. Americas.

The company's recent achievements include advancements in their surgical products and technology, which continue to set industry standards. Current projects are focused on enhancing product efficiency and expanding their global reach through strategic partnerships and innovations.

CONMED's mission centers around improving healthcare quality. Each employee is committed to customer satisfaction and enhanced patient outcomes, reflecting the company's core values. They strive to exhibit thoughtful leadership, provide meaningful opportunities for employees, and act as a responsible corporate citizen in the communities where they operate.

Recent news highlights include ongoing developments in their product lines and strategic initiatives to bolster market presence. With a strong financial foundation and continuous innovation, CONMED remains a pivotal player in the medical technology sector.

Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) to Participate in Fireside Chat at Piper Sandler Healthcare Conference on November 28, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
conferences
-
Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) will participate in fireside chats at two investor conferences in November. The first conference is the Stifel Healthcare Conference in New York, NY on November 14, 2023, where Curt R. Hartman and Eric Staves will be the speakers. The second conference is the Jefferies London Healthcare Conference in London, UK on November 15, 2023, where Todd W. Garner and Pat J. Beyer will be the speakers. The fireside chats will be accessible through the Company's website and will be available for replay.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences
-
Rhea-AI Summary
CONMED Corporation reports third quarter 2023 financial results with sales of $304.6 million, a 10.7% increase YoY. Diluted net earnings per share (GAAP) were $0.50 compared to $1.48 in Q3 2022. The company expects full-year revenue between $1.240 billion and $1.260 billion and adjusted diluted net earnings per share in the range of $3.45 to $3.55.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.95%
Tags
Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) will report Q3 2023 financial results on October 25. Conference call at 4:30 p.m. ET to discuss the results. Webcast replay available on company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.5%
Tags
-
Rhea-AI Summary
CONMED Corporation CFO to participate in virtual fireside chat at CL King 21st Annual Best Ideas Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.4%
Tags
conferences
-
Rhea-AI Summary
CONMED Corporation CFO to participate in fireside chat at Wells Fargo Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.63%
Tags
conferences
Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share. The dividend will be payable on October 5, 2023, to all shareholders of record as of September 15, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
dividends
-
Rhea-AI Summary
Palliare Signs first US GPO Agreement
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.6%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.3%
Tags

FAQ

What is the current stock price of CONMED Corporation (CNMD)?

The current stock price of CONMED Corporation (CNMD) is $72.24 as of November 15, 2024.

What is the market cap of CONMED Corporation (CNMD)?

The market cap of CONMED Corporation (CNMD) is approximately 2.2B.

What does CONMED Corporation specialize in?

CONMED Corporation specializes in the development and sale of surgical and patient monitoring products across various medical specialties.

Where is CONMED Corporation headquartered?

CONMED Corporation is headquartered in Utica, New York.

How many employees does CONMED Corporation have?

CONMED Corporation employs approximately 3,500 individuals.

What are the main product specialties of CONMED Corporation?

The main product specialties include orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology.

What are the primary reporting units of CONMED Corporation?

The primary reporting units are Orthopedic Surgery and General Surgery.

In which regions does CONMED Corporation generate most of its revenue?

CONMED Corporation generates most of its revenue in the U.S., followed by the EMEA region, APAC, and the non-U.S. Americas.

What is the mission of CONMED Corporation?

CONMED's mission is to improve healthcare quality by designing, producing, and marketing innovative, high-quality products.

How does CONMED Corporation ensure customer and patient satisfaction?

CONMED focuses on thoughtful leadership, employee opportunities, and responsible community engagement to ensure customer and patient satisfaction.

What recent achievements has CONMED Corporation made?

Recent achievements include advancements in surgical products and technology, enhancing product efficiency and global reach through strategic partnerships.

What is CONMED Corporation's approach to innovation?

CONMED emphasizes continuous innovation by setting industry standards and focusing on product improvements that enhance clinical outcomes.

CONMED Corporation

NYSE:CNMD

CNMD Rankings

CNMD Stock Data

2.17B
30.83M
0.58%
119.54%
7.96%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
LARGO